This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 40 and 78
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

To investigate the safety and the efficacy of perampanel in patients with sporadic amyotrophic lateral sclerosis

Provided treatments

  • Drug: Perampanel
  • Drug: placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03019419. The sponsor of the trial is Tokyo Medical University and it is looking for 66 volunteers for the current phase.
Official trial title:
Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS): A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Trials